# Configurations

| UniProt Accession Number   | Reagent Type     | Target Name / Protein Biomarker   | Target Species   | Host Organism   | Isotype   | Clonality   | Vendor   | Catalog Number   | Conjugate   | RRID      | Availability   | Method        | Tissue Preservation   | Target Tissue   | Tissue State    | Detergent         | Antigen Retrieval Conditions                                  | Dye Inactivation Conditions   | Recommend   | Agree               | Disagree   | Contributor         | Notes       |
|:---------------------------|:-----------------|:----------------------------------|:-----------------|:----------------|:----------|:------------|:---------|:-----------------|:------------|:----------|:---------------|:--------------|:----------------------|:----------------|:----------------|:------------------|:--------------------------------------------------------------|:------------------------------|:------------|:--------------------|:-----------|:--------------------|:------------|
| P07766                     | Primary Antibody | CD3                               | Human            | Rabbit          | IgG       | EP4426      | Abcam    | ab208514         | AF555       | AB_443425 | Stock          | IBEX2D Manual | FFPE                  | Cervix          | Cervical Cancer | 0.3% Triton-X-100 | pH 6 for 40 minutes at 95C (AR6 Akoya Biosciences AR600250ML) | 1 mg/ml LiBH4 15 minutes      | Yes         | 0000-0002-7586-9996 | NA         | 0000-0002-7586-9996 | [1](#notes) |
| P07766                     | Primary Antibody | CD3                               | Human            | Rabbit          | IgG       | EP4426      | Abcam    | ab208514         | AF555       | AB_443425 | Stock          | IBEX2D Manual | FFPE                  | Skin            | NA              | 0.3% Triton-X-100 | pH 6 for 40 minutes at 95C (AR6 Akoya Biosciences AR600250ML) | 1 mg/ml LiBH4 15 minutes      | Yes         | 0000-0002-7586-9996 | NA         | 0000-0002-7586-9996 | [1](#notes) |

# Publications



# Additional Notes

<a name="notes"></a>
1. Evaluated in human FFPE samples with CD8 and Hoechst (nuclear marker). Antibody yields anticipated staining pattern. Performed using manual IBEX protocol with antibody incubation using the Pelco Biowave microwave.
